Position in SIGA
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$577
-$7,011 QoQ
Shares Held
108
-91.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $2,428,042 across 29 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
42,686 | $684,256 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
10,265 | $347,778 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
9,055 | $222,843 | |
| 4 | VTRS |
Viatris Inc
|
11,789 | $187,209 | |
| 5 | HLN |
Haleon plc
|
16,968 | $158,311 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
737 | $124,213 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
182 | $98,613 | |
| 8 | ZTS |
Zoetis Inc.
|
1,244 | $89,393 |
All Filings in SIGA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $577 | 108 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $7,588 | 1,242 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $11,364 | 1,242 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $8,097 | 1,242 | Shares | Sole | 2025-07-07 | |
| No filing history on record for this holder in this stock. | ||||||